Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Therapeuticsmd Inc (TXMD)

Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Therapeuticsmd Inc 951 Yamato Road Suite 220 BOCA RATON FL 33431 USA

www.therapeuticsmd.com Employees: 1 P: 561-961-1900

Sector:

Medical

Description:

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.

Key Statistics

Overview:

Market Capitalization, $K 25,810
Enterprise Value, $K 20,750
Shares Outstanding, K 11,574
Float, K 11,377
% Float 98.30%
Short Interest, K 67
Short Float 0.58%
Days to Cover 1.03
Short Volume Ratio 0.22
% of Insider Shareholders 1.70%
% of Institutional Shareholders 30.74%

Financials:

Annual Sales, $ 1,760 K
Annual Net Income, $ -2,180 K
Last Quarter Sales, $ 780 K
Last Quarter Net Income, $ 150 K
EBIT, $ -2,370 K
EBITDA, $ -1,860 K

Growth:

1-Year Return 114.42%
3-Year Return -59.38%
5-Year Return -97.03%
5-Year Revenue Growth -96.46%
5-Year Earnings Growth 99.74%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 11/12/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Qtr -100.00%
EPS Growth vs. Prev Year 100.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 05/09/22

TXMD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.27%
Return-on-Assets % 0.19%
Profit Margin % -123.86%
Debt/Equity 0.00
Price/Sales 9.22
Price/Cash Flow N/A
Price/Book 0.94
Book Value/Share 2.37
Interest Coverage -0.61
60-Month Beta 0.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar